{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T21:51:03Z","timestamp":1786657863082,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["U24CA076518"],"award-info":[{"award-number":["U24CA076518"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["N00014-23-1-2057"],"award-info":[{"award-number":["N00014-23-1-2057"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["N00014-24-1-2057"],"award-info":[{"award-number":["N00014-24-1-2057"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U24HL138660"],"award-info":[{"award-number":["U24HL138660"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75R60222C00011"],"award-info":[{"award-number":["75R60222C00011"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75R60222C00009"],"award-info":[{"award-number":["75R60222C00009"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75R60222C00008"],"award-info":[{"award-number":["75R60222C00008"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jtct.2024.08.015","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T17:10:33Z","timestamp":1725037833000},"page":"1092-1098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["CAST Regimen for GvHD Prophylaxis: A CIBMTR Propensity Score-Matched Analysis"],"prefix":"10.1016","volume":"30","author":[{"given":"A Samer","family":"Al-Homsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd E.","family":"DeFor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Cirrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1407-5332","authenticated-orcid":false,"given":"Stephanie","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Suarez-Londono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Yaghmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5487-2363","authenticated-orcid":false,"given":"Stephanie","family":"Boisclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0766-1162","authenticated-orcid":false,"given":"Caitrin","family":"Bupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-8252","authenticated-orcid":false,"given":"Stephen R.","family":"Spellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jtct.2024.08.015_bib0001","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/bloodadvances.2016002196","article-title":"Related haploidentical donors are a better choice than matched unrelated donors: point","volume":"1","author":"Fuchs","year":"2017","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jtct.2024.08.015_bib0002","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood.2021011281","article-title":"HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis","volume":"138","author":"Gooptu","year":"2021","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.jtct.2024.08.015_bib0003","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1182\/bloodadvances.2022007741","article-title":"HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score natching and donor age","volume":"6","author":"Ambinder","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2024.08.015_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.11.028","article-title":"Haploidentical versus matched unrelated donor transplant using post-transplant cyclophosphamide for lymphomas","volume":"29","author":"Mussetti","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"14","key":"10.1016\/j.jtct.2024.08.015_bib0005","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1182\/bloodadvances.2023010545","article-title":"PTCy, abatacept, and a short course of tacrolimus for GvHD prevention after haploidentical transplantation","volume":"7","author":"Al-Homsi","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2024.08.015_bib0006","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"issue":"17","key":"10.1016\/j.jtct.2024.08.015_bib0008","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copland","year":"2006","journal-title":"NEJM"},{"issue":"3","key":"10.1016\/j.jtct.2024.08.015_bib0009","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5581\/1516-8484.20110060","article-title":"Advances in haploidentical stem cell transplantation","volume":"33","author":"Bayraktar","year":"2011","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"21","key":"10.1016\/j.jtct.2024.08.015_bib0010","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1182\/blood.2019001323","article-title":"How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide","volume":"134","author":"McCurdy","year":"2019","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jtct.2024.08.015_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.04.012","article-title":"Updated trends in hematopoietic cell transplantation in the United States with an additional focus on adolescent and young adult transplantation activity and outcomes","volume":"28","author":"Phelan","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"10.1016\/j.jtct.2024.08.015_bib0012","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/bbmt.2002.v8.pm12171484","article-title":"Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide","volume":"8","author":"O'Donnell","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2024.08.015_bib0013","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.08.015_bib0014","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/bmt.2014.108","article-title":"Haploidentical transplantation using G-CSF-mobilized T-cell replete PBSCs and post-transplantation CY after non-myeloablative conditioning is safe and is associated with favorable outcomes","volume":"49","author":"Bhamidipati","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.08.015_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.00636","article-title":"Post-transplant Cyclophosphamide: from HLA-haploidentical to matched-related and matched unrelated donor blood and marrow transplantation","volume":"11","author":"Williams","year":"2020","journal-title":"Front Immunol"},{"issue":"25","key":"10.1016\/j.jtct.2024.08.015_bib0016","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Balanos-Meade","year":"2023","journal-title":"NEJM"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2024.08.015_bib0017","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1182\/blood-2023-174821","volume":"142","author":"Nagler","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.08.015_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.02668","article-title":"Mechanisms of graft-versus-host disease prevention by post-transplantation cyclophosphamide: an evolving understanding","volume":"10","author":"Nunes","year":"2019","journal-title":"Front Immunol"},{"issue":"17","key":"10.1016\/j.jtct.2024.08.015_bib0019","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1200\/JCO.20.01086","article-title":"Phase II trial of costimulation blockade with abatacept for prevention of acute GvHD","volume":"39","author":"Watkins","year":"2021","journal-title":"JCO"},{"issue":"5","key":"10.1016\/j.jtct.2024.08.015_bib0020","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.bbmt.2018.01.011","article-title":"Shortened-duration tacrolimus after nonmyeloablative, HLA-haploidentical bone marrow transplantation","volume":"24","author":"Kassamon","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2024.08.015_bib0021","doi-asserted-by":"crossref","first-page":"e83913","DOI":"10.1371\/journal.pone.0083913","article-title":"CD86 is an activation receptor for NK cell cytotoxicity against tumor cells","volume":"8","author":"Peng","year":"2013","journal-title":"PLoS ONE"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2024.08.015_bib0022","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood-2023-186402","article-title":"MMF is associated with worse OS in CMV seropositive AML patients undergoing MUD HCT with calcineurin-inhibitor-based GvHD prophylaxis","volume":"142","author":"Saliba","year":"2023","journal-title":"Blood"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724006080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724006080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T01:53:08Z","timestamp":1762048388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636724006080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2666636724006080"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2024.08.015","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CAST Regimen for GvHD Prophylaxis: A CIBMTR Propensity Score-Matched Analysis","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2024.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}